Tin tức & Cập nhật
Xem bài viết Tim mạch
Xem
Febuxostat vs benzbromarone: Which is more effective in CKD with hyperuricaemia, hypertension?
Treatment with either febuxostat or benzbromarone results in comparable outcomes among patients with stage G3 chronic kidney disease (CKD) with asymptomatic hyperuricaemia and hypertension, a study has shown.
Febuxostat vs benzbromarone: Which is more effective in CKD with hyperuricaemia, hypertension?
13 Aug 2023
TV habits in childhood may impact metabolic health in mid-adulthood
Children and teens who watch a lot of television often grow to be adults with metabolic syndrome, obesity, or poor fitness, according to a study.
TV habits in childhood may impact metabolic health in mid-adulthood
10 Aug 2023
Impaired RV function, pulmonary coupling tied to hospitalizations, death in HFpEF patients
Worsening right ventricular (RV) function normally occurs in patients with heart failure and preserved left ventricular ejection fraction (HFpEF) and, along with its ratio to pulmonary pressure, is predictive of a higher risk of HF hospitalizations and cardiovascular death, reports a study.
Impaired RV function, pulmonary coupling tied to hospitalizations, death in HFpEF patients
09 Aug 2023
GLP-1 RA, with or without SGLT2 inhibitors, prevents cardiac events in T2D
Treatment with the glucagon-like peptide-1 receptor agonist (GLP-1 RA) albiglutide results in fewer cardiovascular events, irrespective of sodium-glucose cotransporter-2 (SGLT2) inhibitor use, among patients with type 2 diabetes (T2D) and cardiovascular disease, according to the post hoc analysis of Harmony Outcomes*.
GLP-1 RA, with or without SGLT2 inhibitors, prevents cardiac events in T2D
08 Aug 2023
Long daytime naps tied to increased AF risk
Power naps (<30 minutes) offer time to recharge but going beyond the 30-minute mark may not be heart-friendly, according to a study that found a link between long daytime naps and risk of developing atrial fibrillation (AF).